Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corp
(NQ:
TWST
)
58.08
+0.57 (+0.99%)
Official Closing Price
Updated: 4:15 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
Next >
Twist Bioscience Earnings Preview
February 01, 2024
Via
Benzinga
Twist Bioscience Corp Daily Investment Opportunity
January 25, 2024
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries.
Via
Talk Markets
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
January 17, 2024
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
Twist Bioscience: Q4 Earnings Insights
November 17, 2023
Via
Benzinga
Why Shares of Twist Bioscience Are Up Friday
August 04, 2023
The company reported improved financials in the third quarter.
Via
The Motley Fool
Twist Bioscience Stock Soars After Q3 Report - Here's Why
August 04, 2023
Twist Bioscience Corp (NASDAQ: TWST) reported Q3 sales increased 14% Y/Y to $63.7 million, beating the consensus of $60.71 million.
Via
Benzinga
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout
December 12, 2023
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same.
Via
Talk Markets
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
Five Best Performing Stocks Of The Top ETF Of November
December 01, 2023
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way.
Via
Talk Markets
Topics
ETFs
Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up'
November 21, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc.
Via
Benzinga
Twist Bioscience's Earnings Outlook
August 03, 2023
Via
Benzinga
Analyst Ratings for Twist Bioscience
July 13, 2023
Via
Benzinga
S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings
November 17, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow traded up 0.07% to 34,969.63 while the NASDAQ rose 0.21% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 17, 2023
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
November 17, 2023
U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The S&P 500 also rose, gaining, 0.05% to 4,510.71.
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
November 17, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its Peers
November 17, 2023
The company expects sales to grow 16% to 18% in fiscal year 2024, which is already underway.
Via
Investor's Business Daily
Why Synthetic DNA Company Twist Bioscience Shares Are Jumping Today
November 17, 2023
Twist Bioscience Corp's (NASDAQ: TWST) Q4 sales increased 16.8% Y/Y to $66.9 million,
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential
August 11, 2023
DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry.
Via
InvestorPlace
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 04, 2023
Via
Benzinga
Earnings Scheduled For August 4, 2023
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
2 Cathie Wood Growth Stocks That Could Make You Richer
July 18, 2023
These two biotechs could be winning plays for aggressive investors.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.